UPDATE: Bank of America Reiterates on Aviv REIT Following Mixed 4Q Results
In a report published Thursday, Bank of America analyst Juan C. Sanabria reiterated an Underweight rating on Aviv REIT (NYSE: AVIV), and raised the price target from $23.00 to $23.50.
In the report, Bank of America noted, “Within our coverage, healthcare REIT earnings results were mixed. HCN, HCP & NHI exceeded; AVIV, SNH & VTR met; and MPW missed. AVIV, HCN, HCP, MPW & NHI all initiated 2014 guidance below Street expectations due largely to the exclusion of future acquisitions in company forecasts. VTR was the only REIT that initiated guidance in line with expectations. SNH does not provide guidance. Specifically, VTR initiated same store (SS) cash NOI growth guidance of 3-4% across its portfolio, and is expecting SS RIDEA growth of 4-6%. HCN is expecting 3-3.5% overall SS cash NOI growth with RIDEA 5% or greater. HCP is forecasting 3-4% overall cash SS NOI growth with senior housing at 3.5-4.5%.”
Aviv REIT closed on Wednesday at $25.69.
Latest Ratings for AVIV
|Nov 2014||RBC Capital||Downgrades||Outperform||Sector Perform|
|Nov 2014||SunTrust Robinson Humphrey||Downgrades||Buy||Neutral|
|Nov 2014||Stifel Nicolaus||Downgrades||Buy||Hold|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.